Temple’s $900 BrainFlow Wearable Faces Scientific Scrutiny

A sensor attached beside the forehead can produce a compelling graph. Establishing what that graph says about the brain is a different challenge. Temple, the wearable developed by Indian entrepreneur Deepinder Goyal, is now facing that distinction in public. Reuters covered the dispute over the roughly $900 device on November 11.

The location alone is not a breakthrough. A 2020 swimming study placed a Polar OH1 optical heart-rate sensor beneath a swim cap at the temple. Twenty-six trained swimmers also wore a chest reference and a wristwatch. The head-mounted sensor performed well in that setting, but the experiment concerned heart rate. It did not establish a measurement of circulation inside the brain.

Optical pulse sensing, commonly called PPG, shines light into skin and reads changes associated with the heartbeat. Imagine watching a light through several curtains: detecting a change is easier than identifying precisely where it originated. With a head-worn device, the important question becomes how much the signal reflects deeper circulation rather than blood vessels near the skin.

Temple points to early validation work on its research page. The company describes a study of 23 healthy adults comparing its BrainFlow index with transcranial Doppler ultrasound, which measures blood speed in major cerebral arteries. It reports correlated changes and labels the work as undergoing peer review. BrainFlow remains a company-defined index, not a direct readout of how many millilitres of blood pass through the brain each minute.

Speaking to The Indian Express, neurologist Neeraj Jain called for stronger validation of how specifically this device measures circulation within the skull. That is a question about interpretation, not merely whether a sensor responds. Two thermometers rising together would not establish that both measure the same room. Correlated physiological signals likewise need a carefully defined relationship before one can stand in for the other.

Temple's ambitions extend further. Its homepage describes Entropy as an indicator of the body's work in releasing heat and combines resting and active readings into an overall score. The research page also states that the product is not a medical device and is not intended to diagnose or treat disease. The consumer issue is therefore concrete: an interesting way to observe oneself and a number with established health meaning are different purchases. Independent validation will need to explain the distance between them, rather than leaving customers to infer it from an impressive-looking chart.

Controversy reported: November 11, 2026.